Published in Liver Transpl on September 01, 2002
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
Identification of liver transplant candidates with hepatocellular carcinoma and a very low dropout risk: implications for the current organ allocation policy. Liver Transpl (2013) 2.53
MELD score and serum sodium in the prediction of survival of patients with cirrhosis awaiting liver transplantation. Gut (2007) 2.09
Predictive indices of morbidity and mortality after liver resection. Ann Surg (2006) 2.01
Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt. Gut (2003) 1.76
Serum sodium, renal function, and survival of patients with end-stage liver disease. J Hepatol (2010) 1.62
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl (2007) 1.58
Health-related quality of life and survival in liver transplant candidates. Liver Transpl (2010) 1.55
HCC patients suffer less from geographic differences in organ availability. Am J Transplant (2013) 1.52
Intention to treat outcome of T1 hepatocellular carcinoma with the "wait and not ablate" approach until meeting T2 criteria for liver transplant listing. Liver Transpl (2016) 1.49
Stage of cirrhosis predicts the risk of liver-related death in patients with low Model for End-Stage Liver Disease scores and cirrhosis awaiting liver transplantation. Liver Transpl (2014) 1.48
The model for end-stage liver disease score is useful for predicting economic outcomes in adult cases of living donor liver transplantation. J Gastroenterol (2006) 1.47
Daclizumab induction therapy in liver transplant recipients with renal insufficiency. Aliment Pharmacol Ther (2010) 1.40
Kidney, pancreas and liver allocation and distribution in the United States. Am J Transplant (2012) 1.24
The ethics and reality of rationing in medicine. Chest (2011) 1.24
2014 KLCSG-NCC Korea Practice Guideline for the Management of Hepatocellular Carcinoma. Gut Liver (2015) 1.23
Model for end-stage liver disease: end of the first decade. Clin Liver Dis (2011) 1.20
Predictors of minimal hepatic encephalopathy in patients with cirrhosis. Saudi J Gastroenterol (2010) 1.20
Clinical usefulness of measuring red blood cell distribution width in patients with hepatitis B. PLoS One (2012) 1.19
Therapy for alcoholic liver disease. World J Gastroenterol (2014) 1.17
2014 Korean Liver Cancer Study Group-National Cancer Center Korea practice guideline for the management of hepatocellular carcinoma. Korean J Radiol (2015) 1.14
Updates in the management of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) (2011) 1.07
Outcomes after liver transplant in patients aged 70 years or older compared with those younger than 60 years. Mayo Clin Proc (2009) 1.07
Differential effects of plasma and red blood cell transfusions on acute lung injury and infection risk following liver transplantation. Liver Transpl (2011) 1.06
Prioritization for liver transplantation. Nat Rev Gastroenterol Hepatol (2010) 1.05
Clinical relevance of sarcopenia in patients with cirrhosis. World J Gastroenterol (2014) 1.03
Laparoscopic cholecystectomy in cirrhotic patients: the value of MELD score and Child-Pugh classification in predicting outcome. Surg Endosc (2009) 1.02
Height contributes to the gender difference in wait-list mortality under the MELD-based liver allocation system. Am J Transplant (2010) 0.99
Influence of serum sodium on MELD-based survival prediction in alcoholic hepatitis. Mayo Clin Proc (2011) 0.98
Surgical treatment of hepatocellular carcinoma. Surg Today (2009) 0.97
Model for end-stage liver disease predicts mortality for tricuspid valve surgery. Ann Thorac Surg (2009) 0.95
Revision of MELD to include serum albumin improves prediction of mortality on the liver transplant waiting list. PLoS One (2013) 0.93
Predictors of survival following liver transplantation in infants: a single-center analysis of more than 200 cases. Transplantation (2010) 0.92
Pediatric liver transplantation outcomes in Korea. J Korean Med Sci (2013) 0.91
Cancer and liver cirrhosis: implications on prognosis and management. ESMO Open (2016) 0.91
Hepatocellular Carcinoma and Liver Transplantation: State of the Art. J Clin Transl Hepatol (2014) 0.90
Model for end-stage liver disease versus the Child-Pugh score in predicting the post-transplant 3-month and 1-year mortality in a cohort of Chinese recipients. Surg Today (2009) 0.87
Predicting morbidity and mortality after hepatic resection in patients with hepatocellular carcinoma: the role of Model for End-Stage Liver Disease score. World J Surg (2009) 0.86
Transjugular intrahepatic porto-systemic shunt in the elderly: Palliation for complications of portal hypertension. World J Hepatol (2012) 0.85
Model for end-stage liver disease (MELD) score, as a prognostic factor for post-operative morbidity and mortality in cirrhotic patients, undergoing hepatectomy for hepatocellular carcinoma. HPB (Oxford) (2009) 0.85
Red blood cell distribution width: a potential maker estimating disease activity of ankylosing spondylitis. Int J Clin Exp Med (2014) 0.83
Modification of acid-base balance in cirrhotic patients undergoing liver resection for hepatocellular carcinoma. Ann Surg (2007) 0.83
Liver transplantation in the MELD era: a single-center experience. Dig Dis Sci (2006) 0.83
Long-term experience with liver transplantation for hepatocellular carcinoma. J Gastroenterol (2010) 0.83
Outcome of using small-for-size grafts in living donor liver transplantation recipients with high model for end-stage liver disease scores: a single center experience. PLoS One (2013) 0.82
Rate of observation and inter-observer agreement for LI-RADS major features at CT and MRI in 184 pathology proven hepatocellular carcinomas. Abdom Radiol (2016) 0.82
Extending survival with the use of targeted therapy in the treatment of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) (2013) 0.82
Impact of estimated liver volume and liver weight on gender disparity in liver transplantation. Liver Transpl (2012) 0.81
Impact of the current organ allocation system for deceased donor liver transplantation on the outcomes of pediatric recipients: a single center experience in Japan. Pediatr Surg Int (2013) 0.81
Current developments in pediatric liver transplantation. World J Hepatol (2015) 0.81
The Refit model for end-stage liver disease-Na is not a better predictor of mortality than the Refit model for end-stage liver disease in patients with cirrhosis and ascites. Clin Mol Hepatol (2014) 0.80
The Model for End-stage Liver Disease accurately predicts 90-day liver transplant wait-list mortality in Atlantic Canada. Can J Gastroenterol (2011) 0.80
Comparison of seven liver allocation models with respect to lives saved among patients on the liver transplant waiting list. Transpl Int (2012) 0.80
Liver transplantation as a management of hepatocellular carcinoma. World J Hepatol (2015) 0.80
Liver transplantation for hepatocellular carcinoma: outcomes and treatment options for recurrence. Ann Gastroenterol (2015) 0.79
Inclusion of Sarcopenia Within MELD (MELD-Sarcopenia) and the Prediction of Mortality in Patients With Cirrhosis. Clin Transl Gastroenterol (2015) 0.79
Predictive indices of morbidity and mortality after liver resection. Ann Surg (2006) 0.78
Predicting Mortality Across a Broad Spectrum of Liver Disease-An Assessment of Model for End-Stage Liver Disease (MELD), Child-Turcotte-Pugh (CTP), and Creatinine-Modified CTP Scores. J Clin Exp Hepatol (2012) 0.78
Systemic vascular resistance in cirrhosis: a predictor of severity? Hepat Med (2014) 0.78
Current Treatment Approaches to HCC with a Special Consideration to Transplantation. J Transplant (2016) 0.78
Advances in liver transplantation allocation systems. World J Gastroenterol (2016) 0.78
Reduction in liver transplant wait-listing in the era of direct-acting antiviral therapy. Hepatology (2016) 0.77
Application of a biochemical and clinical model to predict individual survival in patients with end-stage liver disease. World J Gastroenterol (2009) 0.77
Molecular prognostic prediction in liver cirrhosis. World J Gastroenterol (2015) 0.77
Kidney function and mortality post-liver transplant in the Model for End-Stage Liver Disease era. Int J Nephrol Renovasc Dis (2011) 0.77
Hepatic resection for hepatocellular carcinoma in patients with portal hypertension: a long-term benefit compared with transarterial chemoembolization and thermal ablation. Medicine (Baltimore) (2015) 0.77
Female gender in the setting of liver transplantation. World J Transplant (2014) 0.77
Mean platelet volume, red cell distribution width, platelet-to-lymphocyte and neutrophil-to-lymphocyte ratios in patients with ankylosing spondylitis and their relationships with high-frequency hearing thresholds. Eur Arch Otorhinolaryngol (2016) 0.77
AST to Platelet Ratio Index Predicts Mortality in Hospitalized Patients With Hepatitis B-Related Decompensated Cirrhosis. Medicine (Baltimore) (2016) 0.76
Serum sphingolipids reflect the severity of chronic HBV infection and predict the mortality of HBV-acute-on-chronic liver failure. PLoS One (2014) 0.76
Recent advances in liver transplantation for the practicing gastroenterologist. Gastroenterol Hepatol (N Y) (2009) 0.76
The effects of magnesium pretreatment on reperfusion injury during living donor liver transplantation. Korean J Anesthesiol (2011) 0.76
Development of a survival evaluation model for liver transplant recipients with hepatocellular carcinoma secondary to hepatitis B. World J Gastroenterol (2008) 0.76
Clinical effectiveness of cell therapies in patients with chronic liver disease and acute-on-chronic liver failure: a systematic review protocol. Syst Rev (2016) 0.76
Serum C-reactive protein predicts early mortality in hospitalized patients with HBV-related decompensated cirrhosis. Medicine (Baltimore) (2017) 0.75
Predicting Outcomes on the Liver Transplant Waiting List in the United States: Accounting for Large Regional Variation in Organ Availability and Priority Allocation Points. Transplantation (2016) 0.75
Successful Simultaneous Liver-Kidney Transplantation in the Presence of Multiple High-Titered Class I and II Antidonor HLA Antibodies. Transplant Direct (2016) 0.75
Introducing an optimal liver allocation system for liver cirrhosis patients. Hepat Mon (2013) 0.75
A 10-Year united network for organ sharing review of mortality and risk factors in young children awaiting liver transplantation. Liver Transpl (2016) 0.75
Model for end-stage liver disease exceptions: proceed with caution. Liver Transpl (2011) 0.75
A new multiparameter integrated MELD model for prognosis of HBV-related acute-on-chronic liver failure. Medicine (Baltimore) (2016) 0.75
Outcomes Between Elderly and Young Hepatocellular Carcinoma Living Donor Liver Transplantation Recipients: A Single-Center Experience. Medicine (Baltimore) (2016) 0.75
Neutrophil-to-Lymphocyte Ratio Predicts Early Mortality in Patients with HBV-Related Decompensated Cirrhosis. Gastroenterol Res Pract (2016) 0.75
Validation of the Model of End-Stage Liver Disease for Liver Transplant Allocation in Alberta: Implications for Future Directions in Canada. Can J Gastroenterol Hepatol (2016) 0.75
Current Status of Liver Allocation in the United States. Gastroenterol Hepatol (N Y) (2016) 0.75
Who Treats Patients with Diabetes and Compensated Cirrhosis. PLoS One (2016) 0.75
Transplantation: Sharing of donated livers is not equal. Nat Rev Gastroenterol Hepatol (2012) 0.75
Massive haemorrhage in liver transplantation: Consequences, prediction and management. World J Transplant (2016) 0.75
Evaluation of mean platelet volume in patients with hepatitis B virus infection. Int J Clin Exp Med (2014) 0.75
Transient elastography compared to liver biopsy and morphometry for predicting fibrosis in pediatric chronic liver disease: Does etiology matter? World J Gastroenterol (2016) 0.75
Pre-operative predictors of red blood cell transfusion in liver transplantation. Blood Transfus (2016) 0.75
Revisiting the role of pathological analysis in transarterial chemoembolization-treated hepatocellular carcinoma after transplantation. World J Gastroenterol (2014) 0.75
Liver failure after hepatocellular carcinoma surgery. Langenbecks Arch Surg (2014) 0.75
Patients' Age Rather Than Model of End-Stage Liver Disease Score Predicts Survival After Liver Transplantation. Dig Dis Sci (2017) 0.75
Overview of Staging Systems for Hepatocellular Carcinoma and Implications for Interventional Radiology. Semin Intervent Radiol (2017) 0.75
Evaluation of Adrenal Function in Nonhospitalized Patients with Cirrhosis. Can J Gastroenterol Hepatol (2017) 0.75
Model for end-stage liver disease (MELD) and allocation of donor livers. Gastroenterology (2003) 10.11
Rifaximin treatment in hepatic encephalopathy. N Engl J Med (2010) 9.60
Hyponatremia and mortality among patients on the liver-transplant waiting list. N Engl J Med (2008) 6.67
Cachexia: a new definition. Clin Nutr (2008) 5.49
Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis. N Engl J Med (2015) 3.13
MELD accurately predicts mortality in patients with alcoholic hepatitis. Hepatology (2005) 2.99
Results of the first year of the new liver allocation plan. Liver Transpl (2004) 2.86
Effect of 10 days of bed rest on skeletal muscle in healthy older adults. JAMA (2007) 2.60
Report of a national conference on liver allocation in patients with hepatocellular carcinoma in the United States. Liver Transpl (2010) 2.57
Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis. Am J Transplant (2005) 2.54
In vivo autofluorescence imaging of the human and macaque retinal pigment epithelial cell mosaic. Invest Ophthalmol Vis Sci (2008) 2.19
Improving liver allocation: MELD and PELD. Am J Transplant (2004) 2.14
Donor-specific HLA Antibodies Are Associated With Late Allograft Dysfunction After Pediatric Liver Transplantation. Transplantation (2015) 2.13
Natural history of hepatopulmonary syndrome: Impact of liver transplantation. Hepatology (2005) 2.05
Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials. Hepatology (2005) 1.97
Health-related quality of life and family function following pediatric liver transplantation. Liver Transpl (2008) 1.90
Light-induced retinal changes observed with high-resolution autofluorescence imaging of the retinal pigment epithelium. Invest Ophthalmol Vis Sci (2008) 1.89
Portopulmonary hypertension: Results from a 10-year screening algorithm. Hepatology (2006) 1.87
Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C. Liver Transpl (2003) 1.86
A pilot study of the safety and tolerability of etanercept in patients with alcoholic hepatitis. Am J Gastroenterol (2004) 1.83
Evolving frequency and outcomes of liver transplantation based on etiology of liver disease. Transplantation (2013) 1.78
Chronic renal dysfunction late after liver transplantation. Liver Transpl (2002) 1.74
Analysis of long-term outcomes of 3200 liver transplantations over two decades: a single-center experience. Ann Surg (2005) 1.73
Report of the first international liver transplantation society expert panel consensus conference on renal insufficiency in liver transplantation. Liver Transpl (2009) 1.69
Long-term survival and impact of ursodeoxycholic acid treatment for recurrent primary biliary cirrhosis after liver transplantation. Liver Transpl (2007) 1.69
Celiac disease autoantibodies in severe autoimmune liver disease and the effect of liver transplantation. Liver Int (2008) 1.62
Liver transplantation for hepatocellular carcinoma: the MELD impact. Liver Transpl (2004) 1.58
MELD score as a predictor of pretransplant and posttransplant survival in OPTN/UNOS status 1 patients. Hepatology (2004) 1.57
Living kidney donor follow-up: state-of-the-art and future directions, conference summary and recommendations. Am J Transplant (2011) 1.51
Hepatopulmonary syndrome: favorable outcomes in the MELD exception era. Hepatology (2013) 1.50
The Bali STD/AIDS Study: evaluation of an intervention for sex workers. Sex Transm Dis (2002) 1.46
Intravitreal injection of AAV2 transduces macaque inner retina. Invest Ophthalmol Vis Sci (2011) 1.46
Risk factors for and clinical course of non-anastomotic biliary strictures after liver transplantation. Am J Transplant (2003) 1.46
Optimizing staging for hepatocellular carcinoma before liver transplantation: A retrospective analysis of the UNOS/OPTN database. Liver Transpl (2006) 1.41
Scirrhous changes in dysplastic nodules do not indicate high-grade status. J Gastroenterol Hepatol (2003) 1.41
Functional impact of 10 days of bed rest in healthy older adults. J Gerontol A Biol Sci Med Sci (2008) 1.39
Trends in waiting list registration for liver transplantation for viral hepatitis in the United States. Gastroenterology (2009) 1.35
MELD and other factors associated with survival after liver transplantation. Am J Transplant (2004) 1.34
Simulating the allocation of organs for transplantation. Health Care Manag Sci (2004) 1.31
Enteral nutritional support in prevention and treatment of pressure ulcers: a systematic review and meta-analysis. Ageing Res Rev (2005) 1.29
Ultrasound-assisted percutaneous liver biopsy performed by a physician assistant. Am J Gastroenterol (2002) 1.29
In vivo imaging of microscopic structures in the rat retina. Invest Ophthalmol Vis Sci (2009) 1.28
Long-term patient outcome and quality of life after liver transplantation: analysis of 20-year survivors. Ann Surg (2010) 1.28
In vivo imaging of the fine structure of rhodamine-labeled macaque retinal ganglion cells. Invest Ophthalmol Vis Sci (2008) 1.24
Pretransplant model to predict posttransplant survival in liver transplant patients. Ann Surg (2002) 1.22
Identification of hepatocytic and bile ductular cell lineages and candidate stem cells in bipolar ductular reactions in cirrhotic human liver. Hepatology (2007) 1.21
Delayed hepatocellular carcinoma model for end-stage liver disease exception score improves disparity in access to liver transplant in the United States. Hepatology (2015) 1.20
In-vivo imaging of retinal nerve fiber layer vasculature: imaging histology comparison. BMC Ophthalmol (2009) 1.20
Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA. Liver Transpl (2004) 1.19
Patterns of medication use in the RRI-CKD study: focus on medications with cardiovascular effects. Nephrol Dial Transplant (2005) 1.12
Evidence-based evolution of the MELD/PELD liver allocation policy. Liver Transpl (2005) 1.11
The evolution of liver transplantation during 3 decades: analysis of 5347 consecutive liver transplants at a single center. Ann Surg (2013) 1.08
Long-term results and modeling to predict outcomes in recipients with HCV infection: results of the NIDDK liver transplantation database. Liver Transpl (2004) 1.08
Impact of cytomegalovirus infection, year of transplantation, and donor age on outcomes after liver transplantation for hepatitis C. Liver Transpl (2002) 1.08
Preemptive use of oral ganciclovir to prevent cytomegalovirus infection in liver transplant patients: a randomized, placebo-controlled trial. J Infect Dis (2002) 1.00
Incentives for organ donation: proposed standards for an internationally acceptable system. Am J Transplant (2011) 0.99
Impact of depressive symptoms and their treatment on completing antiviral treatment in patients with chronic hepatitis C. J Clin Gastroenterol (2010) 0.99
Model for end-stage liver disease (MELD) exception for bacterial cholangitis. Liver Transpl (2006) 0.98
A randomized trial using ultrasound to identify the high-risk fetus in a low-risk population. Obstet Gynecol (2003) 0.98
Infectious enteritis after intestinal transplantation: incidence, timing, and outcome. Transplantation (2005) 0.97
Predictors of outcomes after pediatric liver transplantation: an analysis of more than 800 cases performed at a single institution. J Am Coll Surg (2007) 0.97
A randomized, multicenter study comparing steroid-free immunosuppression and standard immunosuppression for liver transplant recipients with chronic hepatitis C. Liver Transpl (2011) 0.97
The sickest first? Disparities with model for end-stage liver disease-based organ allocation: one region's experience. Liver Transpl (2003) 0.96
Safety and efficacy of ambrisentan for the treatment of portopulmonary hypertension. Chest (2010) 0.95
Disruption of P-selectin signaling modulates cell trafficking and results in improved outcomes after mouse warm intestinal ischemia and reperfusion injury. Transplantation (2005) 0.94
Fidaxomicin versus conventional antimicrobial therapy in 59 recipients of solid organ and hematopoietic stem cell transplantation with Clostridium difficile-associated diarrhea. Antimicrob Agents Chemother (2013) 0.94
Acquired (non-Wilsonian) hepatocerebral degeneration: complex management decisions. Liver Transpl (2003) 0.93
Pediatric transplantation. Am J Transplant (2003) 0.93
CD62 blockade with P-Selectin glycoprotein ligand-immunoglobulin fusion protein reduces ischemia-reperfusion injury after rat intestinal transplantation. Transplantation (2005) 0.93
Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy. Liver Transpl (2002) 0.92
Predictors of survival following liver transplantation in infants: a single-center analysis of more than 200 cases. Transplantation (2010) 0.92
Intrahepatic portal cavernoma as an indication for liver transplantation. Liver Transpl (2007) 0.91
Differential allograft gene expression in acute cellular rejection and recurrence of hepatitis C after liver transplantation. Liver Transpl (2002) 0.90
Analysis of factors that predict alcohol relapse following liver transplantation. Liver Transpl (2004) 0.89
A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C. Hepatology (2002) 0.89
Dynamics of cytomegalovirus replication during preemptive therapy with oral ganciclovir. J Infect Dis (2003) 0.89
Does MELD work for relisted candidates? Liver Transpl (2004) 0.88
Isoniazid-related hepatic failure in children: a survey of liver transplantation centers. Transplantation (2007) 0.88
Pulmonary contraindications, indications and MELD exceptions for liver transplantation: a contemporary view and look forward. J Hepatol (2013) 0.87
Recurrence of primary biliary cirrhosis after liver transplantation: Histologic estimate of incidence and natural history. Liver Transpl (2003) 0.87
Regional sharing for adult status 1 candidates: reduction in waitlist mortality. Liver Transpl (2006) 0.86
Use of sirolimus in liver transplant recipients with renal insufficiency: a systematic review and meta-analysis. Hepatology (2010) 0.86
Preliminary results: outcome of liver transplantation for hepatitis B virus varies by hepatitis B virus genotype. Liver Transpl (2002) 0.86
Protein turnover and amino acid transport kinetics in end-stage renal disease. Am J Physiol Endocrinol Metab (2003) 0.86
Liver transplant for mixed capillary-cavernous hemangioma masquerading as hepatocellular carcinoma in a patient with hepatocellular carcinoma. Exp Clin Transplant (2011) 0.86
Coordinated increase in albumin, fibrinogen, and muscle protein synthesis during hemodialysis: role of cytokines. Am J Physiol Endocrinol Metab (2004) 0.86
Markers of inflammation, proteolysis, and apoptosis in ESRD. Am J Kidney Dis (2003) 0.86
Endoscopy Following Pediatric Intestinal Transplant. J Pediatr Gastroenterol Nutr (2015) 0.85